GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Rite Aid Corp (FRA:RTA1) » Definitions » Debt-to-EBITDA

Rite Aid (FRA:RTA1) Debt-to-EBITDA : -1.88 (As of Aug. 2023)


View and export this data going back to 1970. Start your Free Trial

What is Rite Aid Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Rite Aid's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Aug. 2023 was €3,847 Mil. Rite Aid's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Aug. 2023 was €2,188 Mil. Rite Aid's annualized EBITDA for the quarter that ended in Aug. 2023 was €-3,213 Mil. Rite Aid's annualized Debt-to-EBITDA for the quarter that ended in Aug. 2023 was -1.88.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Rite Aid's Debt-to-EBITDA or its related term are showing as below:

FRA:RTA1' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -903.74   Med: 5.18   Max: 15.75
Current: -5.88

During the past 13 years, the highest Debt-to-EBITDA Ratio of Rite Aid was 15.75. The lowest was -903.74. And the median was 5.18.

FRA:RTA1's Debt-to-EBITDA is ranked worse than
100% of 428 companies
in the Healthcare Providers & Services industry
Industry Median: 2.555 vs FRA:RTA1: -5.88

Rite Aid Debt-to-EBITDA Historical Data

The historical data trend for Rite Aid's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rite Aid Debt-to-EBITDA Chart

Rite Aid Annual Data
Trend Feb14 Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -903.69 13.24 15.75 -107.81 -22.78

Rite Aid Quarterly Data
Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.96 26.15 -11.37 -8.87 -1.88

Competitive Comparison of Rite Aid's Debt-to-EBITDA

For the Pharmaceutical Retailers subindustry, Rite Aid's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rite Aid's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Rite Aid's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Rite Aid's Debt-to-EBITDA falls into.



Rite Aid Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Rite Aid's Debt-to-EBITDA for the fiscal year that ended in Feb. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(475.158 + 4960.269) / -238.563
=-22.78

Rite Aid's annualized Debt-to-EBITDA for the quarter that ended in Aug. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(3847.355 + 2187.66) / -3213.188
=-1.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Aug. 2023) EBITDA data.


Rite Aid  (FRA:RTA1) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Rite Aid Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Rite Aid's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Rite Aid (FRA:RTA1) Business Description

Traded in Other Exchanges
Address
1200 Intrepid Avenue, PO Box 3165, Philadelphia, PA, USA, 17105
Rite Aid Corp is a large retail drugstore chain in the United States. The company reports via two segments: retail pharmacy and pharmacy services. The retail pharmacy segment generates revenue primarily through the sale of prescription drugs, along with an assortment of merchandise that includes over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and numerous other everyday consumables. The pharmacy-services segment relates to EnvisionRx, a fully owned subsidiary that operates as a pharmacy benefit management provider offering a broad range of pharmaceutical services.

Rite Aid (FRA:RTA1) Headlines

No Headlines